{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:38:13Z","timestamp":1788482293502,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFD0501302"],"award-info":[{"award-number":["2018YFD0501302"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872504"],"award-info":[{"award-number":["31872504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010038","name":"China Agriculture Research System","doi-asserted-by":"publisher","award":["CARS-40-K18"],"award-info":[{"award-number":["CARS-40-K18"]}],"id":[{"id":"10.13039\/501100010038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010038","name":"China Agriculture Research System","doi-asserted-by":"publisher","award":["2015BAD12803"],"award-info":[{"award-number":["2015BAD12803"]}],"id":[{"id":"10.13039\/501100010038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.vaccine.2020.09.039","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T09:08:49Z","timestamp":1601024929000},"page":"7337-7349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Protection of chicks from Newcastle disease by combined vaccination with a plasmid DNA and the pre-fusion protein of the virulent genotype VII of Newcastle disease virus"],"prefix":"10.1016","volume":"38","author":[{"given":"Junfeng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.09.039_b0005","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1128\/JVI.00367-11","article-title":"Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens","volume":"85","author":"Kumar","year":"2011","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.20506\/rst.19.2.1231","article-title":"Newcastle disease and other avian paramyxoviruses","volume":"19","author":"Alexander","year":"2000","journal-title":"Rev Sci Tech."},{"key":"10.1016\/j.vaccine.2020.09.039_b0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virusres.2014.02.016","article-title":"Newcastle disease virus: current status and our understanding","volume":"184","author":"Ganar","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.vaccine.2020.09.039_b0020","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.meegid.2012.07.012","article-title":"Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes","volume":"12","author":"Diel","year":"2012","journal-title":"Infect Genet Evol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virusres.2005.11.009","article-title":"Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications","volume":"120","author":"Czegl\u00e9di","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.vaccine.2020.09.039_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.103917","article-title":"Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus","volume":"74","author":"Dimitrov","year":"2019","journal-title":"Infect Genet Evol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vetmic.2016.12.019","article-title":"Newcastle disease vaccines-A solved problem or a continuous challenge?","volume":"206","author":"Dimitrov","year":"2017","journal-title":"Vet Microbiol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/03079457.2012.697991","article-title":"The long view: a selective review of 40 years of Newcastle disease research","volume":"41","author":"Alexander","year":"2012","journal-title":"Avian Pathol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0045","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1128\/JCM.39.10.3512-3519.2001","article-title":"Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan","volume":"39","author":"Yu","year":"2001","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/JCM.01356-07","article-title":"Pathotypical characterization and molecular epidemiology of Newcastle disease virus isolates from different hosts in China from 1996 to 2005","volume":"46","author":"Qin","year":"2008","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0055","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00705-003-0014-z","article-title":"Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985\u20132001","volume":"148","author":"Liu","year":"2003","journal-title":"Arch Virol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11262-014-1075-7","article-title":"Characterization of complete genome sequence of genotype VI and VII velogenic Newcastle disease virus from Japan","volume":"49","author":"Umali","year":"2014","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2020.09.039_b0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1637\/10379-092112-ResNote.1","article-title":"Genetic and antigenic variation of shedding viruses from vaccinated chickens after challenge with virulent Newcastle disease virus","volume":"57","author":"Choi","year":"2013","journal-title":"Avian Dis."},{"key":"10.1016\/j.vaccine.2020.09.039_b0070","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.vaccine.2017.09.008","article-title":"The role of vaccination in risk mitigation and control of Newcastle disease in poultry","volume":"35","author":"Mayers","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.039_b0075","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1016\/j.vaccine.2018.11.008","article-title":"Recombinant infectious laryngotracheitis virus expressing Newcastle disease virus F protein protects chickens against infectious laryngotracheitis virus and Newcastle disease virus challenge","volume":"36","author":"Shao","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.039_b0080","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.vaccine.2008.11.091","article-title":"A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics","volume":"27","author":"Hu","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.039_b0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1637\/9935-091511-Reg.1","article-title":"Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions","volume":"56","author":"Palya","year":"2012","journal-title":"Avian Dis."},{"key":"10.1016\/j.vaccine.2020.09.039_b0090","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2307\/1591910","article-title":"Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies","volume":"37","author":"Morgan","year":"1993","journal-title":"Avian Dis."},{"key":"10.1016\/j.vaccine.2020.09.039_b0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0042-6822(90)90408-J","article-title":"A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV","volume":"178","author":"Boursnell","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.09.039_b0100","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1016\/j.vaccine.2007.07.017","article-title":"Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge","volume":"25","author":"Miller","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.039_b0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/v9080225","article-title":"Effects of the HN antigenic difference between the vaccine strain and the challenge strain of Newcastle disease virus on virus shedding and transmission","volume":"9","author":"Liu","year":"2017","journal-title":"Viruses."},{"key":"10.1016\/j.vaccine.2020.09.039_b0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1637\/8407-071208-Reg.1","article-title":"Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses","volume":"53","author":"Miller","year":"2009","journal-title":"Avian Dis."},{"key":"10.1016\/j.vaccine.2020.09.039_b0115","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1128\/JVI.01931-09","article-title":"Assembly and biological and immunological properties of Newcastle disease virus-like particles","volume":"84","author":"McGinnes","year":"2010","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0120","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1128\/JVI.73.6.5001-5009.1999","article-title":"Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence","volume":"73","author":"Peeters","year":"1999","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0125","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1128\/JVI.76.24.13028-13033.2002","article-title":"Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion","volume":"76","author":"Takimoto","year":"2002","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0130","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1099\/vir.0.19416-0","article-title":"Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity","volume":"84","author":"R\u00f6mer-Oberd\u00f6rfer","year":"2003","journal-title":"J Gen Virol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0135","doi-asserted-by":"crossref","first-page":"E3844","DOI":"10.1073\/pnas.1608349113","article-title":"Immobilization of the N-terminal helix stabilizes prefusion paramyxovirus fusion proteins","volume":"113","author":"Song","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.vaccine.2020.09.039_b0140","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.3390\/v6083019","article-title":"Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production","volume":"6","author":"El Najjar","year":"2014","journal-title":"Viruses."},{"key":"10.1016\/j.vaccine.2020.09.039_b0145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0969-2126(01)00581-0","article-title":"The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion","volume":"9","author":"Chen","year":"2001","journal-title":"Structure."},{"key":"10.1016\/j.vaccine.2020.09.039_b0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1297-9716-42-122","article-title":"Virulence of Newcastle disease virus: what is known so far?","volume":"42","author":"Dortmans","year":"2011","journal-title":"Vet Res."},{"key":"10.1016\/j.vaccine.2020.09.039_b0155","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.09.039_b0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.virol.2010.03.050","article-title":"Structure of the Newcastle disease virus F protein in the post-fusion conformation","volume":"402","author":"Swanson","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.09.039_b0165","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1128\/JVI.00555-11","article-title":"Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes","volume":"85","author":"McLellan","year":"2011","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0170","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3389\/fimmu.2017.01643","article-title":"Functional impairment of mononuclear phagocyte system by the human respiratory syncytial virus","volume":"8","author":"Bohmwald","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0175","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1099\/jgv.0.000959","article-title":"ICTV virus taxonomy profile: pneumoviridae","volume":"98","author":"Rima","year":"2017","journal-title":"J Gen Virol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0180","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1115941109","article-title":"Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention","volume":"109","author":"Magro","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.vaccine.2020.09.039_b0185","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1038\/ncomms9143","article-title":"A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism","volume":"6","author":"Krarup","year":"2015","journal-title":"Nat Commun."},{"key":"10.1016\/j.vaccine.2020.09.039_b0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-017-0005-9","article-title":"Protection of calves by a prefusion-stabilized bovine RSV F vaccine","volume":"2","author":"Zhang","year":"2017","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2020.09.039_b0195","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3389\/fmicb.2018.00751","article-title":"Induction of avian beta-defensin 2 is possibly mediated by the p38 MAPK signal pathway in chicken embryo fibroblasts after Newcastle disease virus infection","volume":"9","author":"Liu","year":"2018","journal-title":"Front Microbiol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0200","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.vaccine.2017.03.045","article-title":"Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge","volume":"35","author":"Zhao","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.039_b0205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0210","doi-asserted-by":"crossref","first-page":"20141","DOI":"10.1074\/jbc.M116.772897","article-title":"Chicken galectin-1B inhibits Newcastle disease virus adsorption and replication through binding to hemagglutinin-neuraminidase (HN) glycoprotein","volume":"292","author":"Sun","year":"2017","journal-title":"J Biol Chem."},{"key":"10.1016\/j.vaccine.2020.09.039_b0215","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/1040638717709855","article-title":"Genetic, antigenic, and pathogenic characteristics of Newcastle disease viruses isolated from geese in China","volume":"29","author":"Xu","year":"2017","journal-title":"J Vet Diagn Invest."},{"key":"10.1016\/j.vaccine.2020.09.039_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nprot.2008.197","article-title":"Protein structure homology modeling using SWISS-MODEL workspace","volume":"4","author":"Bordoli","year":"2009","journal-title":"Nat Protoc."},{"key":"10.1016\/j.vaccine.2020.09.039_b0225","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/JCM.42.1.329-338.2004","article-title":"Development of a real-time reverse-transcription PCR for detection of newcastle disease virus RNA in clinical samples","volume":"42","author":"Wise","year":"2004","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0230","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/03079450600920984","article-title":"Infectious bronchitis virus: S1 gene characteristics of vaccines used in China and efficacy of vaccination against heterologous strains from China","volume":"35","author":"Liu","year":"2006","journal-title":"Avian Pathol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0235","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/03079459808419370","article-title":"Transmission of infectious bronchitis virus within vaccinated and unvaccinated groups of chickens","volume":"27","author":"de Wit","year":"1998","journal-title":"Avian Pathol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0240","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2016.03.003","article-title":"Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens","volume":"130","author":"Li","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.vaccine.2020.09.039_b0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nature04322","article-title":"Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation","volume":"439","author":"Yin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.09.039_b0250","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.09.039_b0255","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/JVI.76.9.4634-4642.2002","article-title":"Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin","volume":"76","author":"Yang","year":"2002","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0260","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0264-410X(95)00254-X","article-title":"Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus","volume":"14","author":"Sakaguchi","year":"1996","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.039_b0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.vetimm.2005.03.005","article-title":"Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes","volume":"106","author":"Loke","year":"2005","journal-title":"Vet Immunol Immunopathol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0270","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/03079457.2016.1144870","article-title":"Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens","volume":"45","author":"Mohamed","year":"2016","journal-title":"Avian Pathol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vetimm.2011.07.006","article-title":"Immunomodulation of bivalent Newcastle disease DNA vaccine induced immune response by co-delivery of chicken IFN-gamma and IL-4 genes","volume":"144","author":"Sawant","year":"2011","journal-title":"Vet Immunol Immunopathol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0280","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr Opin Immunol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0285","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime-boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0290","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0264-410X(01)00430-3","article-title":"DNA vaccination with map1 gene followed by protein boost augments protection against challenge with Cowdria ruminantium, the agent of heartwater","volume":"20","author":"Nyika","year":"2002","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.039_b0295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0264-410X(00)00157-2","article-title":"Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime\/protein boost vaccine","volume":"19","author":"Billaut-Mulot","year":"2000","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.09.039_b0300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vetmic.2012.12.017","article-title":"DNA prime-protein boost strategy with replicase-based DNA vaccine against foot-and-mouth disease in bovine calves","volume":"163","author":"Dar","year":"2013","journal-title":"Vet Microbiol."},{"key":"10.1016\/j.vaccine.2020.09.039_b0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.vetmic.2013.01.027","article-title":"DNA prime-protein boost vaccination enhances protective immunity against infectious bursal disease virus in chickens","volume":"164","author":"Gao","year":"2013","journal-title":"Vet Microbiol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20311993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20311993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:49:03Z","timestamp":1759402143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20311993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":61,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0264410X20311993"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection of chicks from Newcastle disease by combined vaccination with a plasmid DNA and the pre-fusion protein of the virulent genotype VII of Newcastle disease virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}